Minerva Neurosciences (NERV) Misses Q4 EPS by 2540c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($25.51), $25.40 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Blue Owl Credit Income Corp caps Q2 tender offer at 5% of shares
• Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
• Domino's Pizza (DPZ) PT Lowered to $375 at UBS on 'Near-Term Category/Brand Headwinds'